The Patent Finder

Alitair Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Alitair Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Alitair Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,808,743Benzonatate Compositions and Methods of Use
Lapsed on the fee record
Ended Aug 19, 2026 · Medium confidence
Lapsed on the fee recordEnded Aug 19, 2026Medium confidence
US 8,617,602Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
Lapsed on the fee record
Ended Dec 31, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 31, 2025USPTO record
US 8,357,398Benzonatate Compositions and Methods of Use
Lapsed on the fee record
Ended Jan 22, 2025 · High confidence
Lapsed on the fee recordEnded Jan 22, 2025High confidence
US 8,187,617Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
Lapsed on the fee record
Ended May 29, 2024 · USPTO record
Lapsed on the fee recordEnded May 29, 2024USPTO record
US 9,211,292Preventing or reducing drug abuse and overdose events
Lapsed on the fee record
Ended Dec 15, 2023 · USPTO record
Lapsed on the fee recordEnded Dec 15, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited